January 10th 2023:
Intestinal bacteria may be an important piece in the jigsaw puzzle of multiple sclerosis
Years of work on the gut microbiota in multiple sclerosis has finally been completed with a publication in Genome Medicine. The study shows a clear difference in gut microbiota between patients with MS and controls and identify two bacterial species which may have immunoregulatory and disease-modifying effects. To read more: RH webside
The Danish Multiple Sclerosis Center (DMSC) is the leading center for treatment and research in multiple sclerosis in Denmark, and has been awarded Global Excellence in Health.
DMSC provides care for more than 3,500 MS patients, offering both basic and highly specialized therapy. More than 40 employees at the DMSC are engaged in research activities. The focus of the research in DMSC is clinical research, and translational research aiming at implementing the findings from the multidisciplinary research unit of DMSC into new therapies of MS.
The DMSC is located at Rigshospitalet, Nordre Ringvej 57, 2600 Glostrup, Denmark.
The DMSC Clinic is situated at entrance 3, 6th floor, Red Center (Valdemar Hansens Vej 13), the Clinical Diagnostic and Research Laboratories at entrance 5, 7th floor, Green Center (Valdemar Hansens Vej 17) and the Danish MS Registry at entrance 8, 2th floor (Valdemar Hansens Vej 2).